OTCMKTS:DSRLF DiaSorin (DSRLF) Stock Price, News & Analysis $109.60 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock About DiaSorin Stock (OTCMKTS:DSRLF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DiaSorin alerts:Sign Up Key Stats Today's Range$109.60▼$109.6050-Day Range$100.26▼$109.6052-Week Range$100.26▼$109.60VolumeN/AAverage Volume107 shsMarket Capitalization$6.00 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company OverviewDiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.Read More… Remove Ads Receive DSRLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter. Email Address DSRLF Stock News HeadlinesDiaSorin S.p.A. (0GZX) Receives a Hold from BarclaysMarch 25, 2025 | markets.businessinsider.comDiaSorin S.p.A. (0GZX) Receives a Sell from Kepler CapitalMarch 19, 2025 | markets.businessinsider.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.March 30, 2025 | Porter & Company (Ad)DiaSorin stock rises despite mixed financial resultsMarch 17, 2025 | in.investing.comDiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | seekingalpha.comItaly's DiaSorin ex-Covid revenue in line with guidanceMarch 14, 2025 | reuters.comUBS Remains a Hold on DiaSorin S.p.A. (0GZX)March 6, 2025 | markets.businessinsider.comKepler Capital Sticks to Its Sell Rating for DiaSorin S.p.A. (0GZX)March 5, 2025 | markets.businessinsider.comSee More Headlines DSRLF Stock Analysis - Frequently Asked Questions How have DSRLF shares performed this year? DiaSorin's stock was trading at $106.8545 at the beginning of 2025. Since then, DSRLF shares have increased by 2.6% and is now trading at $109.60. View the best growth stocks for 2025 here. How do I buy shares of DiaSorin? Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today3/30/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryMisc. Current SymbolOTCMKTS:DSRLF CIKN/A Webwww.diasoringroup.com Phone391614871FaxN/AEmployees3,186Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.12 Quick Ratio1.89 Sales & Book Value Annual Sales$1.24 billion Price / Sales4.83 Cash Flow$9.71 per share Price / Cash Flow11.29 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares54,710,000Free FloatN/AMarket Cap$6.00 billion OptionableNot Optionable Beta0.24 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:DSRLF) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaSorin S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaSorin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.